Oral low-dose rapamycin treatment prevents aortic aneurysms in marfan mice

Back

ESC Premium Access

Oral low-dose rapamycin treatment prevents aortic aneurysms in marfan mice

Session: Mechanisms of thoracic aortic disease and their treatment

Topic: Pathophysiology and Mechanisms

Speaker: Doctor M. Zaradzki (Heidelberg, DE)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Marcin Zaradzki

University Hospital Heidelberg, Heidelberg (Germany)

0 follower

5 more presentations in this session

PI 3-kinase/AKT/FOXO1 signaling in smooth muscle cells protects against abdominal aortic aneurysm

Speaker: Doctor M. Vantler (Cologne, DE)

Mechanosensitive Ion Channel Piezo1 regulates tight junctions between endothelium and mediates the occurrence of aortic dissection

Speaker: Doctor P. Teng (Hangzhou, CN)

Comparative insights into type non-A non-B vs type B acute aortic syndromes and their blood pressure management: a monocentric, retrospective, 11-year study

Speaker: Doctor F. Burgazzi (Bologna, IT)

Cardiovascular health in women with turner's syndrome: a 3-year single centre audit

Speaker: Miss R. Macrae (London, GB)

Efficacy of beta blockers in patients with thoracic aortic aneurysm: meta-analysis of randomized controlled trials

Speaker: Assistant Professor L. Tanriverdi (Malatya, TR)

Access the full session

Mechanisms of thoracic aortic disease and their treatment

Speakers: Doctor M. Zaradzki, Doctor M. Vantler, Doctor P. Teng, Doctor F. Burgazzi, Miss R. Macrae...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources